| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
B, Mediates the Transcriptional Inhibition of ß-Casein by Tumor Necrosis Factor-
Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, New York 14263
Address all correspondence and requests for reprints to: Margot M. Ip, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, New York 14263. E-mail: margot.ip{at}roswellpark.org.
TNF-
is a physiological regulator of mammary gland development that stimulates the growth of both normal and malignant mammary epithelial cells in primary culture and inhibits functional differentiation. To understand how TNF exerts its effects, the current study examined the mechanism by which TNF down-regulates expression of the ß-casein and whey acidic protein (WAP) genes. TNF treatment markedly decreased activity of the ß-casein and WAP promoters in transiently transfected HC11 mammary epithelial cells. Overexpression of the nuclear factor-
B (NF
B) p50 and/or p65 proteins increased the transcriptional activity of the ß-casein and WAP promoters in HC11 cells, suggesting that the inhibitory effect of TNF on transcription of these genes is not mediated by NF
B. This was further confirmed in experiments in which an NF
B super-repressor was overexpressed, and by deletion of an NF
B binding site in the ß-casein promoter. In contrast, we found that TNF induced both nuclear expression and the DNA-binding activity of liver-enriched inhibitory protein (LIP) isoform of CCAAT/enhancer-binding protein ß. Moreover, cotransfection of LIP and ß-casein expression vectors showed that LIP suppressed the transcriptional activity of the ß-casein promoter. Together, these results suggest that LIP plays a critical role in mediating TNF-induced down-regulation of the ß-casein gene.
This article has been cited by other articles:
![]() |
M. A. Warren, S. F. Shoemaker, D. J. Shealy, W. Bshar, and M. M. Ip Tumor necrosis factor deficiency inhibits mammary tumorigenesis and a tumor necrosis factor neutralizing antibody decreases mammary tumor growth in neu/erbB2 transgenic mice Mol. Cancer Ther., September 1, 2009; 8(9): 2655 - 2663. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, M. A. Warren, S. F. Shoemaker, and M. M. Ip NF{kappa}B1/p50 Is Not Required for Tumor Necrosis Factor-Stimulated Growth of Primary Mammary Epithelial Cells: Implications for NF{kappa}B2/p52 and RelB Endocrinology, January 1, 2007; 148(1): 268 - 278. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |